Integrin (cid:1) D (cid:2) 2 , an adhesion receptor up-regulated on macrophage foam cells, exhibits multiligand-binding properties

Integrin αDβ2, the most recently discovered member of the β2 subfamily of integrin adhesion receptors, is up-regulated on macrophage foam cells. Although other members of the subfamily have been subjects of extensive research, the recognition specificity and the molecular basis for αDβ2 ligand binding remain unknown. Based on the high extent of structural homology between αDβ2 and the major myeloid-cell-specific integrin αMβ2 (Mac-1), noted for its capacity to bind multiple ligands, we considered that the 2 integrins have similar recognition specificity. In this study, using recombinant and natural αDβ2-expressing cells, we demonstrate that αDβ2 supports adhesion and migration to many extracellular matrix proteins in a fashion similar to αMβ2. Consistent with these data, the recombinant αDI-domain of the receptor bound selected ligands. The binding was activation-dependent because the αDI-domain with its C-terminal α7 helix truncated, but not the form with the C-terminal part extended, bound ligands. When the αDI-domain segment Lys244-Lys260 (highly homologous to its αMI-domain counterpart Lys245-Arg261 responsible for αMβ2 multiligand-binding properties) was inserted into the mono-specific αLI-domain, the chimeric protein bound many ligands with affinities similar to those of wild-type αDI-domain. These results establish integrin αDβ2 as a multiligand receptor and indicate that the mechanism whereby αDβ2 exhibits broad ligand specificity resembles that used by αMβ2, the most promiscuous member of the integrin family.

[1]  E. Fisher,et al.  Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Ugarova,et al.  Characterization of plasminogen as an adhesive ligand for integrins αMβ2 (Mac-1) and α5β1 (VLA-5) , 2004 .

[3]  A. Lichtenberg,et al.  Expression of CYR61, an Angiogenic Immediate Early Gene, in Arteriosclerosis and Its Regulation by Angiotensin II , 2002, Circulation.

[4]  L. Lau,et al.  Identification of a novel integrin alphaMbeta2 binding site in CCN1 (CYR61), a matricellular protein expressed in healing wounds and atherosclerotic lesions. , 2003, The Journal of biological chemistry.

[5]  G. Getz Thematic review series: The Immune System and Atherogenesis. Immune function in atherogenesis Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.R400013-JLR200 , 2005, Journal of Lipid Research.

[6]  I. Chaiken,et al.  Tissue factor regulates plasminogen binding and activation. , 1998, Blood.

[7]  M. Vuento,et al.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. , 1979, The Biochemical journal.

[8]  M. Elices,et al.  VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.

[9]  T. Ugarova,et al.  A molecular basis for integrin alphaMbeta 2 ligand binding promiscuity. , 2002, The Journal of biological chemistry.

[10]  M. Arnaout,et al.  An Isoleucine-based Allosteric Switch Controls Affinity and Shape Shifting in Integrin CD11b A-domain* , 2000, The Journal of Biological Chemistry.

[11]  E. Ruoslahti Fibronectin and its receptors. , 1988, Annual review of biochemistry.

[12]  R. Shankar,et al.  Down regulation of CD11b and CD18 expression in atherosclerotic lesion-derived macrophages. , 1995, The American surgeon.

[13]  M. Humphries,et al.  Integrin structure. , 2000, Biochemical Society transactions.

[14]  T. Ugarova,et al.  Identification of a Novel Recognition Sequence for Integrin αMβ2 within the γ-chain of Fibrinogen* , 1998, The Journal of Biological Chemistry.

[15]  T. Ugarova,et al.  Differential Induction of Gelatinase B (MMP-9) and Gelatinase A (MMP-2) in T Lymphocytes upon α4β1-Mediated Adhesion to VCAM-1 and the CS-1 Peptide of Fibronectin☆ , 2000 .

[16]  L. Lau,et al.  Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins αvβ3 and α6β1 in Human Umbilical Vein Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[17]  E. Plow,et al.  Fibrinogen Is a Ligand for Integrin α5β1 on Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[18]  L. Lau,et al.  Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. , 2002, Blood.

[19]  D. Staunton,et al.  αdβ2 Integrin Is a Ligand for Vascular Cell Adhesion Molecule–1 , 1999, International Archives of Allergy and Immunology.

[20]  F. Fawthrop Inflammation: Basic Principles and Clinical Correlates , 1993 .

[21]  T. Ugarova,et al.  Identification of the Binding Site for Fibrinogen Recognition Peptide γ383–395 within the αMI-Domain of Integrin αMβ2 * , 2001, The Journal of Biological Chemistry.

[22]  T. Springer,et al.  Chemoattractant-regulated mobilization of a novel intracellular compartment in human neutrophils. , 1987, Science.

[23]  M. Hayashi,et al.  Novel purification of vitronectin from human plasma by heparin affinity chromatography. , 1988, Cell structure and function.

[24]  S. Lord,et al.  Sequence γ377−395(P2), but Not γ190−202(P1), Is the Binding Site for the αMI-Domain of Integrin αMβ2 in the γC-Domain of Fibrinogen† , 2003 .

[25]  S. L. McGuire,et al.  Distinct Ligand Binding Sites in the I Domain of Integrin αMβ2 That Differentially Affect a Divalent Cation-dependent Conformation (*) , 1995, The Journal of Biological Chemistry.

[26]  M. Humphries,et al.  The Year 2000 Integrin Model , 2000 .

[27]  T. Ugarova,et al.  The interplay between integrins αmβ2 and α5β1 during cell migration to fibronectin , 2003 .

[28]  D. Witte,et al.  Leukocyte engagement of fibrin(ogen) via the integrin receptor αMβ2/Mac-1 is critical for host inflammatory response in vivo , 2004 .

[29]  R. Liddington,et al.  Two conformations of the integrin A-domain (I-domain): a pathway for activation? , 1995, Structure.

[30]  G. Schmid-Schönbein,et al.  Physiology and pathophysiology of leukocyte adhesion , 1995 .

[31]  D. Staunton,et al.  The leukocyte integrin alpha D beta 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1. , 1999, Journal of immunology.

[32]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[33]  T. Ugarova,et al.  The alternatively spliced αeC domain of human fibrinogen-420 is a novel ligand for leukocyte integrins αMβ2 and αXβ2 , 2001 .

[34]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[35]  T. Ugarova,et al.  Integrin αMβ2-Mediated Cell Migration to Fibrinogen and Its Recognition Peptides , 2001, The Journal of experimental medicine.

[36]  R. Liddington,et al.  Crystal structure of the A domain from the a subunit of integrin CR3 (CD11 b/CD18) , 1995, Cell.

[37]  J. Noti Expression of the myeloid-specific leukocyte integrin gene CD11d during macrophage foam cell differentiation and exposure to lipoproteins. , 2002, International journal of molecular medicine.

[38]  H. Ochs,et al.  Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium. , 1990, The Journal of clinical investigation.

[39]  M. Arnaout,et al.  of the Large Subunit of Mol (Mo1; formerly gp 110), a Surface Glycoprotein Associated with Neutrophil Adhesion , 1984 .

[40]  L. Lau,et al.  Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. , 2002, The Journal of biological chemistry.

[41]  D. Staunton,et al.  A novel leukointegrin, αdβ2, binds preferentially to ICAM-3 , 1995 .

[42]  M. Shimaoka,et al.  Activation-induced Conformational Changes in the I Domain Region of Lymphocyte Function-associated Antigen 1* , 2002, The Journal of Biological Chemistry.

[43]  M. Shimaoka,et al.  An isolated, surface-expressed I domain of the integrin αLβ2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Witte,et al.  Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. , 2004, The Journal of clinical investigation.

[45]  Timothy A. Springer,et al.  Structure and allosteric regulation of the αXβ2 integrin I domain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Craig,et al.  ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway , 1993, The Journal of cell biology.